This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Aug:168:291-292.

doi: 10.1016/j.ajo.2016.05.014. Epub 2016 Jun 4.

Reply

Ehsan Rahimy¹, Abtin Shahlaee², M Ali Khan², Gui-Shuang Ying², Joseph I Maguire², Allen C Ho², Carl D Regillo², Jason Hsu²

Affiliations

PMID: 27270363
DOI: 10.1016/j.ajo.2016.05.014

Comment

Reply

Ehsan Rahimy et al. Am J Ophthalmol. 2016 Aug.

. 2016 Aug:168:291-292.

doi: 10.1016/j.ajo.2016.05.014. Epub 2016 Jun 4.

Authors

Ehsan Rahimy¹, Abtin Shahlaee², M Ali Khan², Gui-Shuang Ying², Joseph I Maguire², Allen C Ho², Carl D Regillo², Jason Hsu²

Affiliations

¹ Philadelphia, Pennsylvania, and Palo Alto, California.
² Philadelphia, Pennsylvania.

PMID: 27270363
DOI: 10.1016/j.ajo.2016.05.014

No abstract available

PubMed Disclaimer

Comment on

Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema.
Rahimy E, Shahlaee A, Khan MA, Ying GS, Maguire JI, Ho AC, Regillo CD, Hsu J. Rahimy E, et al. Am J Ophthalmol. 2016 Apr;164:118-27.e2. doi: 10.1016/j.ajo.2015.12.030. Epub 2015 Dec 31. Am J Ophthalmol. 2016. PMID: 26748058
Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema.
Călugăru D, Călugăru M. Călugăru D, et al. Am J Ophthalmol. 2016 Aug;168:290-291. doi: 10.1016/j.ajo.2016.05.015. Epub 2016 Jun 4. Am J Ophthalmol. 2016. PMID: 27270364 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations